🇺🇸 FDA
Patent

US 11648245

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

granted A61KA61K31/4745A61K31/497

Quick answer

US patent 11648245 (Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/4745, A61K31/497, A61K31/506, A61K31/5377